Cargando…
Melittin Increases Cisplatin Sensitivity and Kills KM-H2 and L-428 Hodgkin Lymphoma Cells
Hodgkin lymphoma (HL) is neoplasia with high cure rates. However, not all patients can be cured with the current treatment. Chemo-resistance of tumor cells is one factor involved in treatment failure. In addition to its pore-forming activity on lipid bilayer membranes, the toxin melittin from bee ve...
Autores principales: | Kreinest, Teresa, Volkmer, Ines, Staege, Martin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795649/ https://www.ncbi.nlm.nih.gov/pubmed/33396195 http://dx.doi.org/10.3390/ijms22010343 |
Ejemplares similares
-
Curcuma Contra Cancer? Curcumin and Hodgkin’s Lymphoma
por: Kewitz, Stefanie, et al.
Publicado: (2013) -
Identification of a putative new therapeutical target for Hodgkin's lymphoma
por: Kewitz, Stefanie, et al.
Publicado: (2015) -
Characterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells
por: Braune, Katarina, et al.
Publicado: (2017) -
Expression of A New Endogenous Retrovirus-Associated Transcript in Hodgkin Lymphoma Cells
por: Schneider, Jana, et al.
Publicado: (2019) -
P056: Variants of the transcription factor ONECUT2 regulate gene expression in Hodgkin Lymphoma cells
por: Lein, Patricia, et al.
Publicado: (2022)